Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

Lilly’s Ebglyss approved by FDA as maintenance dose for atopic dermatitis

This new option for patients allows for as few as six maintenance injections per year

- PMLiVE

The next frontier in clinical trials: navigating multi-disease research with GLP-1s

As GLP-1s redefine the treatment landscape for obesity, they are also promising candidates to influence a wide range of disease pathways

Man reading pamphlet

Where translation falls short in practice

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.

Cuttsy + Cuttsy

- PMLiVE

GSK to acquire biopharma Nuvalent for $10.6bn

Two of Nuvalent’s NSCLC therapies have received FDA Breakthrough Therapy and Orphan Drug Designations

- PMLiVE

CSL’s Privigen approved as measles treatment by European Commission

Cases of measles have been rising in Europe since 2023

- PMLiVE

Roche and Nurix Therapeutics to partner in $2.3bn deal

The companies will co-develop and co-commercialise bexobrutideg across malignant haematology, immunology and neurology

- PMLiVE

Headline trade and market deals are opening doors to greater patient access

Regulatory changes and tariffs have created a positive climate for investment, innovation and, critically, patient access to therapies

- PMLiVE

Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA

In the study, there were improvements in motor function as well as a slowing of neurodegeneration

- PMLiVE

Men’s health: the gap between awareness and action is where men’s lives are lost

Until the gap between what healthcare systems can offer and how men actually engage with them is closed, outcomes will continue to deteriorate

- PMLiVE

Alnylam and Inceptive agree on $2bn AI collaboration

The deal will assist accelerate the discovery of RNAi therapeutics

- PMLiVE

Ardena appoints Ariane de Ganck as Chief Scientific Officer

de Ganck was previously lead of the company’s Drug Product division

- PMLiVE

The words around health matter

The language used in healthcare can influence how people perceive their health, feel about themselves, and engage with treatments. Whole-person communication can help reduce stigma and support better real-world healthcare...

Mednet

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links